Beste Yilmaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Beste Yilmaz has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Umut Ozsoy
Akdeniz University, Faculty of Medicine, Department of Anatomy, Antalya, Turkey
2 shared publications - Aydin Erenmemisoglu
Alpan Farma R&D Ltd., 38039 Kayseri, Turkey
1 shared publication - Ayse Akman
Department of Dermatology and Venereology, Akdeniz University School of Medicine, Antalya, Turkey
1 shared publication - Devrim Demir-Dora
Department of Medical Pharmacology, Faculty of Medicine, Akdeniz University, 07070 Antalya, Turkey
1 shared publication - Ege Alkan1 shared publication
- Emel Dogan Kurtoglu
Novagenix Bioanalytical Drug R&D Centre, 06750 Ankara, Turkey
1 shared publication
Latest Publications
- 4 August 2026
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
Validating a Low-Cost Depth Sensor for Facial Anthropometry: Capabilities and Appropriate Use
Background: Low-cost depth sensors are increasingly proposed for 3D facial capture, with high intraclass correlation coefficients (ICC) cited as evidence of readiness. Intraclass correlation coefficient reflects relative agreement and can stay high even when absolute error is large. Methods: Twelve adults were measured by 2 observers at 16 facial distances. We recomputed device-versus-caliper ICC(3,k), Bland-Altman statistics, observer reliability and measurement error, scan-rescan precision, mean absolute error (MAE), and a tolerance classification, against a structured-light scanner and direct calipers. Results: Device-versus-caliper ICC was high for both classes (0.88 and 0.93). Despite this, the depth-sensor MAE was 2.75 versus 1.64 mm ( P =0.0002), and ICC did not predict absolute error (rho=-0.17, P =0.52). This error matched manual landmark-placement error (SEM 1.6-2.1 mm), so it is only partly device-driven; the sensor was distinguished instead by poorer scan-rescan repeatability (0.84 versus 0.36 mm). On a tolerance scheme, 14 of 16 depth-sensor distances exceeded 2 mm, falling to 7 of 16 for the device-specific component. Conclusions: At a fraction of the cost, the depth sensor reproduces relative ranking well but is less precise on the device-only surface metric. It suits morphometric surveys, ranking, and within-subject monitoring, not high-fidelity reconstruction. A high ICC alone does not establish clinical usability; absolute error must accompany it.
- 4 August 2026
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
Validating a Low-Cost Depth Sensor for Facial Anthropometry: Capabilities and Appropriate Use
Background: Low-cost depth sensors are increasingly proposed for 3D facial capture, with high intraclass correlation coefficients (ICC) cited as evidence of readiness. Intraclass correlation coefficient reflects relative agreement and can stay high even when absolute error is large. Methods: Twelve adults were measured by 2 observers at 16 facial distances. We recomputed device-versus-caliper ICC(3,k), Bland-Altman statistics, observer reliability and measurement error, scan-rescan precision, mean absolute error (MAE), and a tolerance classification, against a structured-light scanner and direct calipers. Results: Device-versus-caliper ICC was high for both classes (0.88 and 0.93). Despite this, the depth-sensor MAE was 2.75 versus 1.64 mm ( P =0.0002), and ICC did not predict absolute error (rho=-0.17, P =0.52). This error matched manual landmark-placement error (SEM 1.6-2.1 mm), so it is only partly device-driven; the sensor was distinguished instead by poorer scan-rescan repeatability (0.84 versus 0.36 mm). On a tolerance scheme, 14 of 16 depth-sensor distances exceeded 2 mm, falling to 7 of 16 for the device-specific component. Conclusions: At a fraction of the cost, the depth sensor reproduces relative ranking well but is less precise on the device-only surface metric. It suits morphometric surveys, ranking, and within-subject monitoring, not high-fidelity reconstruction. A high ICC alone does not establish clinical usability; absolute error must accompany it.
- Open Access
- 11 September 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (18) , 5370
The Efficacy and Safety of CollaSel Pro® Hydrolyzed Collagen Peptide Supplementation without Addons in Improving Skin Health in Adult Females: A Double Blind, Randomized, Placebo-Controlled Clinical Study Using Biophysical and Skin Imaging Techniques
Background: This study aimed to evaluate the efficacy and safety of oral hydrolyzed collagen peptide (HCP) in healthy females by assessing the skin parameters via biophysical and skin imaging techniques. Methods: 112 females were randomly assigned to receive either HCP (n = 57; 10 g CollaSel Pro®) or placebo (n = 55; 10 g maltodextrin) daily for eight weeks. The contribution of HCP to skin elasticity, hydration, and roughness was investigated against a placebo, while the facial soft tissue sagging (RMS) and safety data were also recorded. Results: HCP was associated with significant improvements in skin elasticity (p = 0.009), skin hydration (p ranged from 0.003 to p ranged from 0.002 to p = 0.017), skin hydration (65.8 (18.9) vs. 53.1 (14.9) g/m3, p < 0.001) and skin roughness (40.2 (20.4) vs. 24.9 (20.9) g/m3, p < 0.001) were significantly higher. In the HCP group, week 8 RMS values were significantly lower than baseline values (1.02 (0.21) vs. 1.10 (0.21) mm, p = 0.012). Conclusions: CollaSel Pro® HCP can be considered a well-tolerated, safe product that effectively improves dermal health and the appearance of sagging and ameliorates the signs of the aging process.
- 11 September 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (18) , 5370
Open AccessThe Efficacy and Safety of CollaSel Pro® Hydrolyzed Collagen Peptide Supplementation without Addons in Improving Skin Health in Adult Females: A Double Blind, Randomized, Placebo-Controlled Clinical Study Using Biophysical and Skin Imaging Techniques
Background: This study aimed to evaluate the efficacy and safety of oral hydrolyzed collagen peptide (HCP) in healthy females by assessing the skin parameters via biophysical and skin imaging techniques. Methods: 112 females were randomly assigned to receive either HCP (n = 57; 10 g CollaSel Pro®) or placebo (n = 55; 10 g maltodextrin) daily for eight weeks. The contribution of HCP to skin elasticity, hydration, and roughness was investigated against a placebo, while the facial soft tissue sagging (RMS) and safety data were also recorded. Results: HCP was associated with significant improvements in skin elasticity (p = 0.009), skin hydration (p ranged from 0.003 to p ranged from 0.002 to p = 0.017), skin hydration (65.8 (18.9) vs. 53.1 (14.9) g/m3, p < 0.001) and skin roughness (40.2 (20.4) vs. 24.9 (20.9) g/m3, p < 0.001) were significantly higher. In the HCP group, week 8 RMS values were significantly lower than baseline values (1.02 (0.21) vs. 1.10 (0.21) mm, p = 0.012). Conclusions: CollaSel Pro® HCP can be considered a well-tolerated, safe product that effectively improves dermal health and the appearance of sagging and ameliorates the signs of the aging process.